vs

Side-by-side financial comparison of Health Catalyst, Inc. (HCAT) and SmartStop Self Storage REIT, Inc. (SMA). Click either name above to swap in a different company.

SmartStop Self Storage REIT, Inc. is the larger business by last-quarter revenue ($78.4M vs $74.7M, roughly 1.1× Health Catalyst, Inc.). SmartStop Self Storage REIT, Inc. runs the higher net margin — 3.8% vs -121.9%, a 125.7% gap on every dollar of revenue. On growth, SmartStop Self Storage REIT, Inc. posted the faster year-over-year revenue change (29.4% vs -6.2%). Over the past eight quarters, SmartStop Self Storage REIT, Inc.'s revenue compounded faster (17.3% CAGR vs -0.0%).

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

SmartStop Self Storage REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality self-storage properties. Its portfolio covers multiple U.S. states and Canadian provinces, offering secure, flexible storage solutions for residential customers storing personal belongings and commercial clients storing inventory or seasonal goods.

HCAT vs SMA — Head-to-Head

Bigger by revenue
SMA
SMA
1.1× larger
SMA
$78.4M
$74.7M
HCAT
Growing faster (revenue YoY)
SMA
SMA
+35.5% gap
SMA
29.4%
-6.2%
HCAT
Higher net margin
SMA
SMA
125.7% more per $
SMA
3.8%
-121.9%
HCAT
Faster 2-yr revenue CAGR
SMA
SMA
Annualised
SMA
17.3%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCAT
HCAT
SMA
SMA
Revenue
$74.7M
$78.4M
Net Profit
$-91.0M
$3.0M
Gross Margin
61.2%
Operating Margin
-115.3%
24.0%
Net Margin
-121.9%
3.8%
Revenue YoY
-6.2%
29.4%
Net Profit YoY
-340.3%
2080.0%
EPS (diluted)
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCAT
HCAT
SMA
SMA
Q4 25
$74.7M
$78.4M
Q3 25
$76.3M
$70.4M
Q2 25
$80.7M
$66.8M
Q1 25
$79.4M
$65.4M
Q4 24
$79.6M
$60.6M
Q3 24
$76.4M
$60.2M
Q2 24
$75.9M
$59.2M
Q1 24
$74.7M
$57.0M
Net Profit
HCAT
HCAT
SMA
SMA
Q4 25
$-91.0M
$3.0M
Q3 25
$-22.2M
$5.2M
Q2 25
$-41.0M
$-4.8M
Q1 25
$-23.7M
$-5.5M
Q4 24
$-20.7M
$-150.0K
Q3 24
$-14.7M
$-6.2M
Q2 24
$-13.5M
$-705.0K
Q1 24
$-20.6M
$-1.6M
Gross Margin
HCAT
HCAT
SMA
SMA
Q4 25
61.2%
Q3 25
52.6%
60.9%
Q2 25
59.3%
Q1 25
64.1%
Q4 24
66.3%
Q3 24
47.5%
64.8%
Q2 24
66.4%
Q1 24
65.1%
Operating Margin
HCAT
HCAT
SMA
SMA
Q4 25
-115.3%
24.0%
Q3 25
-22.9%
18.1%
Q2 25
-46.0%
15.4%
Q1 25
-25.4%
26.3%
Q4 24
-22.0%
29.4%
Q3 24
-17.9%
29.4%
Q2 24
-20.8%
29.9%
Q1 24
-30.5%
28.0%
Net Margin
HCAT
HCAT
SMA
SMA
Q4 25
-121.9%
3.8%
Q3 25
-29.1%
7.4%
Q2 25
-50.8%
-7.2%
Q1 25
-29.9%
-8.3%
Q4 24
-26.0%
-0.2%
Q3 24
-19.3%
-10.3%
Q2 24
-17.8%
-1.2%
Q1 24
-27.6%
-2.9%
EPS (diluted)
HCAT
HCAT
SMA
SMA
Q4 25
$-1.29
Q3 25
$-0.32
$0.09
Q2 25
$-0.59
$-0.16
Q1 25
$-0.35
$-0.35
Q4 24
$-0.33
Q3 24
$-0.24
$-0.26
Q2 24
$-0.23
$-0.16
Q1 24
$-0.35
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCAT
HCAT
SMA
SMA
Cash + ST InvestmentsLiquidity on hand
$95.7M
$54.2M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$245.8M
$1.2B
Total Assets
$502.6M
$2.4B
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCAT
HCAT
SMA
SMA
Q4 25
$95.7M
$54.2M
Q3 25
$91.5M
$47.8M
Q2 25
$97.3M
$37.7M
Q1 25
$342.0M
$35.2M
Q4 24
$392.0M
$23.1M
Q3 24
$387.3M
$36.7M
Q2 24
$308.3M
$34.7M
Q1 24
$327.8M
$39.2M
Total Debt
HCAT
HCAT
SMA
SMA
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
HCAT
HCAT
SMA
SMA
Q4 25
$245.8M
$1.2B
Q3 25
$331.9M
$1.2B
Q2 25
$347.5M
$1.2B
Q1 25
$376.8M
$303.0M
Q4 24
$365.2M
$325.7M
Q3 24
$355.0M
$343.9M
Q2 24
$357.0M
$365.8M
Q1 24
$357.2M
$384.8M
Total Assets
HCAT
HCAT
SMA
SMA
Q4 25
$502.6M
$2.4B
Q3 25
$587.1M
$2.4B
Q2 25
$616.2M
$2.3B
Q1 25
$891.5M
$2.1B
Q4 24
$858.9M
$2.0B
Q3 24
$813.0M
$1.9B
Q2 24
$691.7M
$1.9B
Q1 24
$695.1M
$1.9B
Debt / Equity
HCAT
HCAT
SMA
SMA
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCAT
HCAT
SMA
SMA
Operating Cash FlowLast quarter
$9.9M
$85.0M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
28.61×
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCAT
HCAT
SMA
SMA
Q4 25
$9.9M
$85.0M
Q3 25
$-464.0K
$52.1M
Q2 25
$-9.0M
$8.0M
Q1 25
$280.0K
$10.6M
Q4 24
$-3.5M
$64.0M
Q3 24
$6.2M
$21.7M
Q2 24
$1.6M
$17.3M
Q1 24
$10.3M
$14.4M
Free Cash Flow
HCAT
HCAT
SMA
SMA
Q4 25
$9.6M
Q3 25
$-719.0K
Q2 25
$-9.2M
Q1 25
$-390.0K
Q4 24
$-3.9M
Q3 24
$5.5M
Q2 24
$1.3M
Q1 24
$10.1M
FCF Margin
HCAT
HCAT
SMA
SMA
Q4 25
12.9%
Q3 25
-0.9%
Q2 25
-11.4%
Q1 25
-0.5%
Q4 24
-4.9%
Q3 24
7.2%
Q2 24
1.7%
Q1 24
13.5%
Capex Intensity
HCAT
HCAT
SMA
SMA
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.8%
Q4 24
0.5%
Q3 24
0.9%
Q2 24
0.4%
Q1 24
0.3%
Cash Conversion
HCAT
HCAT
SMA
SMA
Q4 25
28.61×
Q3 25
9.96×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

SMA
SMA

Self Storage Rental Revenue$62.0M79%
Other$11.9M15%
Ancillary Operating Revenue$2.9M4%
Asset Management1$1.7M2%

Related Comparisons